Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 2005 Nov;90(6):F514–F519. doi: 10.1136/adc.2004.060434

Potential risk factors for the development of acute renal failure in preterm newborn infants: a case-control study

L Cataldi, R Leone, U Moretti, B De Mitri, V Fanos, L Ruggeri, G Sabatino, F Torcasio, V Zanardo, G Attardo, F Riccobene, C Martano, D Benini, L Cuzzolin
PMCID: PMC1721962  PMID: 16244211

Abstract

Aims: To determine in a case-control study possible associations between the development of acute renal failure in preterm newborns and therapeutic interventions, particularly drug treatments.

Methods: The study population was 172 preterm infants of <38 weeks gestation; 71 had acute renal failure and 101 were controls closely matched for gestational age and birth weight. Maternal and neonatal information was collected for both groups through questionnaires and interviews. Routine data on renal variables were also collected. Univariate and multivariate logistic regression analyses were performed.

Results: Very low birthweight infants were at high risk of acute renal failure (79% of cases were <1500 g). However, the acute renal failure was transient. Mothers of infants with acute renal failure received more drugs during pregnancy and delivery (mainly antibiotics and non-steroidal anti-inflammatory drugs). Of the possible therapeutic interventions, intubation, catheterisation, and phototherapy were mainly applied to case subjects. A low Apgar score and patent ductus arteriosus were diagnosed in a greater percentage of neonates with acute renal failure. Moreover, in the first few days of life and before diagnosis of acute renal failure, case subjects received more drugs (antibiotics, non-steroidal anti-inflammatory drugs, and diuretics) and for a longer time. In the multivariate logistic analysis, medullary hyperechogenicity (odds ratio (OR) 4.491; 95% confidence interval (CI) 1.879 to 10.731) and ceftazidime administration (OR 5.082; 95% CI 1.493 to 17.297) were associated with a greater risk of acute renal failure.

Conclusions: The results suggest the need for careful monitoring of very low birthweight infants and attention to drug treatments, as it is difficult to differentiate between normality and renal failure in the first few days of life.

Full Text

The Full Text of this article is available as a PDF (77.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abitbol Carolyn L., Bauer Charles R., Montané Brenda, Chandar Jayanthi, Duara Shahnaz, Zilleruelo Gastón. Long-term follow-up of extremely low birth weight infants with neonatal renal failure. Pediatr Nephrol. 2003 Jun 27;18(9):887–893. doi: 10.1007/s00467-003-1186-1. [DOI] [PubMed] [Google Scholar]
  2. Cuzzolin L., Dal Cerè M., Fanos V. NSAID-induced nephrotoxicity from the fetus to the child. Drug Saf. 2001 Jan;24(1):9–18. doi: 10.2165/00002018-200124010-00002. [DOI] [PubMed] [Google Scholar]
  3. Dennery P. A., Seidman D. S., Stevenson D. K. Neonatal hyperbilirubinemia. N Engl J Med. 2001 Feb 22;344(8):581–590. doi: 10.1056/NEJM200102223440807. [DOI] [PubMed] [Google Scholar]
  4. Fanos V., Agostiniani R., Cataldi L. Pyelectasis and hydronephrosis in the newborn and infant. Acta Paediatr. 2000 Aug;89(8):900–904. doi: 10.1080/080352500750043305. [DOI] [PubMed] [Google Scholar]
  5. Fanos V., Cataldi L. Antibacterial-induced nephrotoxicity in the newborn. Drug Saf. 1999 Mar;20(3):245–267. doi: 10.2165/00002018-199920030-00005. [DOI] [PubMed] [Google Scholar]
  6. Farrell P. M., Kosorok M. R., Rock M. J., Laxova A., Zeng L., Lai H. C., Hoffman G., Laessig R. H., Splaingard M. L. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics. 2001 Jan;107(1):1–13. doi: 10.1542/peds.107.1.1. [DOI] [PubMed] [Google Scholar]
  7. Gordjani N., Burghard R., Leititis J. U., Brandis M. Serum creatinine and creatinine clearance in healthy neonates and prematures during the first 10 days of life. Eur J Pediatr. 1988 Nov;148(2):143–145. doi: 10.1007/BF00445923. [DOI] [PubMed] [Google Scholar]
  8. Gouyon J. B., Guignard J. P. Management of acute renal failure in newborns. Pediatr Nephrol. 2000 Sep;14(10-11):1037–1044. doi: 10.1007/s004670050068. [DOI] [PubMed] [Google Scholar]
  9. Hentschel R., Lödige B., Bulla M. Renal insufficiency in the neonatal period. Clin Nephrol. 1996 Jul;46(1):54–58. [PubMed] [Google Scholar]
  10. Holmes R. P., Stone P. R. Severe oligohydramnios induced by cyclooxygenase-2 inhibitor nimesulide. Obstet Gynecol. 2000 Nov;96(5 Pt 2):810–811. doi: 10.1016/s0029-7844(00)01047-4. [DOI] [PubMed] [Google Scholar]
  11. Isaacs D. Rationing antibiotic use in neonatal units. Arch Dis Child Fetal Neonatal Ed. 2000 Jan;82(1):F1–F2. doi: 10.1136/fn.82.1.F1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Leonhardt A., Seyberth H. W. Do we need another NSAID instead of indomethacin for treatment of ductus arteriosus in preterm infants? Acta Paediatr. 2003 Sep;92(9):996–999. [PubMed] [Google Scholar]
  13. Linder N., Edwards R., MeClead R., Mortensen M. E., Walson P., Koren G. Safety of vancomycin with or without gentamicin in neonates. Neonatal Netw. 1993 Dec;12(8):27–30. [PubMed] [Google Scholar]
  14. Linder Nehama, Haskin Orli, Levit Orli, Klinger Gil, Prince Tal, Naor Nora, Turner Pol, Karmazyn Boaz, Sirota Lea. Risk factors for intraventricular hemorrhage in very low birth weight premature infants: a retrospective case-control study. Pediatrics. 2003 May;111(5 Pt 1):e590–e595. doi: 10.1542/peds.111.5.e590. [DOI] [PubMed] [Google Scholar]
  15. Nathanson S., Moreau E., Merlet-Benichou C., Gilbert T. In utero and in vitro exposure to beta-lactams impair kidney development in the rat. J Am Soc Nephrol. 2000 May;11(5):874–884. doi: 10.1681/ASN.V115874. [DOI] [PubMed] [Google Scholar]
  16. Ojala R., Ala-Houhala M., Ahonen S., Harmoinen A., Turjanmaa V., Ikonen S., Tammela O. Renal follow up of premature infants with and without perinatal indomethacin exposure. Arch Dis Child Fetal Neonatal Ed. 2001 Jan;84(1):F28–F33. doi: 10.1136/fn.84.1.F28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Peruzzi L., Gianoglio B., Porcellini M. G., Coppo R. Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic. Lancet. 1999 Nov 6;354(9190):1615–1615. doi: 10.1016/S0140-6736(99)03105-0. [DOI] [PubMed] [Google Scholar]
  18. Sakata H., Maruyama S., Ishioka T., Shirai M., Taketazu M., Taketazu G. Change of renal function during vancomycin therapy in extremely low birthweight infants. Acta Paediatr Jpn. 1996 Dec;38(6):619–621. doi: 10.1111/j.1442-200x.1996.tb03719.x. [DOI] [PubMed] [Google Scholar]
  19. Schlondorff D. Renal complications of nonsteroidal anti-inflammatory drugs. Kidney Int. 1993 Sep;44(3):643–653. doi: 10.1038/ki.1993.293. [DOI] [PubMed] [Google Scholar]
  20. Schulz Kenneth F., Grimes David A. Case-control studies: research in reverse. Lancet. 2002 Feb 2;359(9304):431–434. doi: 10.1016/S0140-6736(02)07605-5. [DOI] [PubMed] [Google Scholar]
  21. Smaoui H., Mallie J. P., Cheignon M., Borot C., Schaeverbeke J. Glomerular alterations in rat neonates after transplacental exposure to gentamicin. Nephron. 1991;59(4):626–631. doi: 10.1159/000186655. [DOI] [PubMed] [Google Scholar]
  22. Stapleton F. B., Jones D. P., Green R. S. Acute renal failure in neonates: incidence, etiology and outcome. Pediatr Nephrol. 1987 Jul;1(3):314–320. doi: 10.1007/BF00849230. [DOI] [PubMed] [Google Scholar]
  23. Stoll Barbara J., Hansen Nellie, Fanaroff Avroy A., Wright Linda L., Carlo Waldemar A., Ehrenkranz Richard A., Lemons James A., Donovan Edward F., Stark Ann R., Tyson Jon E. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002 Aug;110(2 Pt 1):285–291. doi: 10.1542/peds.110.2.285. [DOI] [PubMed] [Google Scholar]
  24. Tóth-Heyn P., Drukker A., Guignard J. P. The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor nephropathy. Pediatr Nephrol. 2000 Mar;14(3):227–239. doi: 10.1007/s004670050048. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES